In the News May 23, 2016

The Deal | Xenoport Gets Acquired, But Not by Big Public Pharma

Mark Ray and Sarah Ernst are mentioned for advising Arbor Pharmaceuticals in its acquisition of XenoPort for a total equity value of approximately $467 million.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement